SEARCH

SEARCH BY CITATION

References

  • Adams, R.J., McKie, V.C., Brambilla, D., Carl, E., Gallagher, D., Nichols, F.T., Roach, S., Abboud, M., Berman, B., Driscoll, C., Files, B., Hsu, L., Hurlet, A., Miller, S., Olivieri, N., Pegelow, C., Scher, C., Vichinsky, E., Wang, W., Woods, G., Kutlar, A., Wright, E., Hagner, S., Tighe, F., Lewin, J., Cure, J., Zimmerman, R.A. & Waclawiw, M.A. (1998) Stroke prevention trial in sickle cell anemia. Controlled Clinical Trials, 19, 110129.
  • Araujo, A.N. (2009) Acute splenic sequestration in children with sickle cell anemia. Jornal de Pediatria, 85, 373.
  • Bartolucci, P., Ngo, M.T., Beuzard, Y., Galacteros, F., Saber, G., Rideau, D., Eddahibi, S., Maitre, B., Adnot, S. & Delclaux, C. (2007) Decrease in lung nitric oxide production after peritonitis in mice with sickle cell disease. Critical Care Medicine, 35, 502509.
  • Belcher, J.D., Mahaseth, H., Welch, T.E., Vilback, A.E., Sonbol, K.M., Kalambur, V.S., Bowlin, P.R., Bischof, J.C., Hebbel, R.P. & Vercellotti, G.M. (2005) Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. American Journal of Physiology. Heart and Circulatory Physiology, 288, H2715H2725.
  • Blouin, M.J., Beauchemin, H., Wright, A., De, P.M., Sorette, M., Bleau, A.M., Nakamoto, B., Ou, C.N., Stamatoyannopoulos, G. & Trudel, M. (2000) Genetic correction of sickle cell disease: insights using transgenic mouse models. Nature Medicine, 6, 177182.
  • Bourgeaux, V., Hequet, O., Campion, Y., Delcambre, G., Chevrier, A.M., Rigal, D. & Godfrin, Y. (2010) Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling. Transfusion, 50, 21762184.
  • Choi, K.H., Edelstein, C.L., Gengaro, P., Schrier, R.W. & Nemenoff, R.A. (1995) Hypoxia induces changes in phospholipase A2 in rat proximal tubules: evidence for multiple forms. The American Journal of Physiology, 269, F846F853.
  • Conran, N. & Costa, F.F. (2009) Hemoglobin disorders and endothelial cell interactions. Clinical Biochemistry, 42, 18241838.
  • De Paepe, M.E. & Trudel, M. (1994) The transgenic SAD mouse: a model of human sickle cell glomerulopathy. Kidney International, 46, 13371345.
  • Ergul, S., Brunson, C.Y., Hutchinson, J., Tawfik, A., Kutlar, A., Webb, R.C. & Ergul, A. (2004) Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction. American Journal of Hematology, 76, 245251.
  • de Franceschi, L., Baron, A., Scarpa, A., Adrie, C., Janin, A., Barbi, S., Kister, J., Rouyer-Fessard, P., Corrocher, R., Leboulch, P. & Beuzard, Y. (2003) Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood, 102, 10871096.
  • Gersonde, K. & Weiner, M. (1981) The influence of infusion rate on the acute intravenous toxicity of phytic acid, a calcium-binding agent. Toxicology, 22, 279286.
  • Gladwin, M. & Kato, G. (2007) Hemolysis-Associated Endothelial Dysfunction and Pulmonary Hypertension. Advances in Pulmonary Hypertension, 6, 2330.
  • Gupta, K., Gupta, P., Solovey, A. & Hebbel, R.P. (1999) Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin. Biochimica et Biophysica Acta, 1453, 6373.
  • Hirani, A., Weibel, S. & Kane, G.C. (2011) Acute Chest Syndrome and Other Pulmonary Manifestations of Sickle Cell Disease. Journal of Clinical Outcomes Management, 18, 211221.
  • Hogan, A.M., Pit-ten Cate, I.M., Vargha-Khadem, F., Prengler, M. & Kirkham, F.J. (2006) Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction. Developmental Science, 9, 379387.
  • Josephson, C.D., Su, L.L., Hillyer, K.L. & Hillyer, C.D. (2007) Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfusion Medicine Reviews, 21, 118133.
  • Kaul, D.K., Finnegan, E. & Barabino, G.A. (2009) Sickle red cell-endothelium interactions. Microcirculation, 16, 97111.
  • Kirkham, F.J. & Hogan, A.M. (2004) Risk factors for arterial ischemic stroke in childhood. CNS Spectrums, 9, 451464.
  • Manci, E.A., Hillery, C.A., Bodian, C.A., Zhang, Z.G., Lutty, G.A. & Coller, B.S. (2006) Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease. Blood, 107, 16511658.
  • Miller, S.T., Wright, E., Abboud, M., Berman, B., Files, B., Scher, C.D., Styles, L. & Adams, R.J. (2001) Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. Journal of Pediatrics, 139, 785789.
  • Nagel, R.L. & Fabry, M.E. (2001) The panoply of animal models for sickle cell anaemia. British Journal of Haematology, 112, 1925.
  • Naprawa, J.T., Bonsu, B.K., Goodman, D.G. & Ranalli, M.A. (2005) Serum biomarkers for identifying acute chest syndrome among patients who have sickle cell disease and present to the emergency department. Pediatrics, 116, e420e425.
  • Pászty, C., Brion, C.M., Manci, E., Witkowska, H.E., Stevens, M.E., Mohandas, N. & Rubin, E.M. (1997) Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science, 278, 876878.
  • Pegelow, C.H., Adams, R.J., McKie, V., Abboud, M., Berman, B., Miller, S.T., Olivieri, N., Vichinsky, E., Wang, W. & Brambilla, D. (1995) Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. Journal of Pediatrics, 126, 896899.
  • Pestina, T.I., Hargrove, P.W., Jay, D., Gray, J.T., Boyd, K.M. & Persons, D.A. (2009) Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. Molecular Therapy, 17, 245252.
  • Portilla, D., Mandel, L.J., Bar-Sagi, D. & Millington, D.S. (1992) Anoxia induces phospholipase A2 activation in rabbit renal proximal tubules. The American Journal of Physiology, 262, F354F360.
  • Rees, D.C., Williams, T.N. & Gladwin, M.T. (2010) Sickle-cell disease. Lancet, 376, 20182031.
  • Reiter, C.D. & Gladwin, M.T. (2003) An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Current Opinion in Hematology, 10, 99107.
  • Sasai-Takedatsu, M., Kojima, T., Hirata, Y. & Kobayashi, Y. (1994) Production of endothelin-1 induced by blood transfusion in premature infants. Vox Sanguinis, 67, 368371.
  • Steen, R.G., Emudianughe, T., Hunte, M., Glass, J., Wu, S., Xiong, X. & Reddick, W.E. (2005) Brain volume in pediatric patients with sickle cell disease: evidence of volumetric growth delay? American Journal of Neuroradiology, 26, 455462.
  • Steinberg, M.H. (2008) Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. ScientificWorldJournal., 8, 12951324.
  • Stuart, M.J. & Nagel, R.L. (2004) Sickle-cell disease. Lancet, 364, 13431360.
  • Styles, L.A., Aarsman, A.J., Vichinsky, E.P. & Kuypers, F.A. (2000) Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood, 96, 32763278.
  • Sugihara, K., Sugihara, T., Mohandas, N. & Hebbel, R.P. (1992) Thrombospondin mediates adherence of CD36 +  sickle reticulocytes to endothelial cells. Blood, 80, 26342642.
  • Trudel, M., De Paepe, M.E., Chrétien, N., Saadane, N., Jacmain, J., Sorette, M., Hoang, T. & Beuzard, Y. (1994) Sickle cell disease of transgenic SAD mice. Blood, 84, 31893197.
  • Viprakasit, V., Kankirawatana, S., Akarasereenont, P., Durongpisitkul, K., Chotewuttakorn, S. & Tanphaichitr, V.S. (2002) Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients. American Journal of Hematology, 70, 260262.
  • Wahl, S. & Quirolo, K.C. (2009) Current issues in blood transfusion for sickle cell disease. Current Opinion in Pediatrics, 21, 1521.
  • Walters, M.C., Nienhuis, A.W. & Vichinsky, E. (2002) Novel therapeutic approaches in sickle cell disease. American Society of Hematology. Education Program, 1034.
  • Wayne, A.S., Kevy, S.V. & Nathan, D.G. (1993) Transfusion management of sickle cell disease. Blood, 81, 11091123.
  • Witko-Sarsat, V., Friedlander, M., Capeillere-Blandin, C., Nguyen-Khoa, T., Nguyen, A.T., Zingraff, J., Jungers, P. & Descamps-Latscha, B. (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney International, 49, 13041313.
  • Wood, K.C., Hsu, L.L. & Gladwin, M.T. (2008) Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radical Biology and Medicine, 44, 15061528.